|
Re: RVX rises above 200-day moving average
|
5
|
Resverlogix Corp.
|
Sep 21, 2020 05:22PM
|
|
Canadian funds slow to invest in thriving biotech industry.
|
5
|
Resverlogix Corp.
|
Dec 03, 2020 06:40PM
|
|
Re: Renal trial delayed (again)
|
5
|
Resverlogix Corp.
|
Sep 30, 2017 07:33AM
|
|
Re: Back to the FDA
|
5
|
Resverlogix Corp.
|
Oct 04, 2019 06:26AM
|
|
Re: No news
|
5
|
Resverlogix Corp.
|
Sep 16, 2022 09:42AM
|
|
Re: AGM Resolution
|
5
|
Resverlogix Corp.
|
Nov 30, 2020 07:52AM
|
|
Re: $2.00 financing
|
5
|
Resverlogix Corp.
|
Mar 22, 2017 05:07AM
|
|
Re: All day I've been thinking this is Friday.....
|
5
|
Resverlogix Corp.
|
Nov 19, 2015 05:48PM
|
|
Re: Deal Closing?
|
5
|
Resverlogix Corp.
|
May 29, 2019 07:59AM
|
|
Re: Apabetalone......a Calculated Risk
|
5
|
Resverlogix Corp.
|
Apr 07, 2019 06:57PM
|
|
Re: Actions Speak Louder Than Words
|
5
|
Resverlogix Corp.
|
Dec 01, 2016 07:16PM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
5
|
Zenith Epigenetics
|
Mar 01, 2024 01:25PM
|
|
Re: Is Resverlogix Legit?
|
5
|
Resverlogix Corp.
|
Jul 28, 2019 11:12AM
|
|
Re: Nice to see the.....
|
5
|
Resverlogix Corp.
|
Jan 16, 2020 07:32PM
|
|
Re: Things are happening
|
5
|
Resverlogix Corp.
|
Aug 04, 2018 06:02AM
|
|
Re: Shorts running for cover
|
5
|
Resverlogix Corp.
|
Jun 18, 2018 12:28PM
|
|
Re: Narmac
|
5
|
Resverlogix Corp.
|
Aug 08, 2024 08:43PM
|
|
Re: Curious wording in last private placement ( next 180 days )
|
5
|
Resverlogix Corp.
|
Aug 31, 2016 06:55PM
|
|
Biogen looks to FDA for approval of early Alzheimers drug.
|
5
|
Resverlogix Corp.
|
Oct 22, 2019 07:16AM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
5
|
Zenith Epigenetics
|
Nov 01, 2019 09:16AM
|
